Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan M Robbins

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Pulmonary Circulation|September 30, 2016
Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertensionTufik R Assad, Evan L Brittain, Quinn S Wells, et al.
Journal of the American Heart Association|November 10, 2020
Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial HypertensionEvan L Brittain, Kevin Niswender, Vineet Agrawal, et al.
Journal of the American College of Cardiology|June 27, 2009
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertensionMarius M Hoeper, Joan Albert Barberà, Richard N Channick, et al.
American Journal of Respiratory and Critical Care Medicine|March 2, 2016
Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial HypertensionAnna R Hemnes, Min Zhao, James West, et al.
Journal of Cardiovascular Pharmacology|January 28, 2003
Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertensionVallerie V McLaughlin, Sean P Gaine, Robyn J Barst, et al.
American Journal of Respiratory and Critical Care Medicine|January 31, 2002
Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertensionMarius M Hoeper, Nazzareno Galié, Srinivas Murali, et al.
Chest|October 19, 2013
EIF2AK4 mutations in pulmonary capillary hemangiomatosisD Hunter Best, Kelli L Sumner, Eric D Austin, et al.
Chest|June 6, 2021
Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry: Enrollment Characteristics and 1-Year Follow-upKim M Kerr, C Greg Elliott, Kelly Chin, et al.
American Heart Journal|June 1, 2002
Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertensionDavid Langleben, Brian W Christman, Robyn J Barst, et al.
American Heart Journal|August 23, 2006
Temporal trends and drug exposures in pulmonary hypertension: an American experienceAlexander M Walker, David Langleben, James J Korelitz, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Pulmonary Circulation|September 30, 2016
Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertensionTufik R Assad, Evan L Brittain, Quinn S Wells, et al.
Journal of the American Heart Association|November 10, 2020
Mechanistic Phase II Clinical Trial of Metformin in Pulmonary Arterial HypertensionEvan L Brittain, Kevin Niswender, Vineet Agrawal, et al.
Journal of the American College of Cardiology|June 27, 2009
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertensionMarius M Hoeper, Joan Albert Barberà, Richard N Channick, et al.
American Journal of Respiratory and Critical Care Medicine|March 2, 2016
Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial HypertensionAnna R Hemnes, Min Zhao, James West, et al.
Journal of Cardiovascular Pharmacology|January 28, 2003
Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertensionVallerie V McLaughlin, Sean P Gaine, Robyn J Barst, et al.
American Journal of Respiratory and Critical Care Medicine|January 31, 2002
Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertensionMarius M Hoeper, Nazzareno Galié, Srinivas Murali, et al.
Chest|October 19, 2013
EIF2AK4 mutations in pulmonary capillary hemangiomatosisD Hunter Best, Kelli L Sumner, Eric D Austin, et al.
Chest|June 6, 2021
Results From the United States Chronic Thromboembolic Pulmonary Hypertension Registry: Enrollment Characteristics and 1-Year Follow-upKim M Kerr, C Greg Elliott, Kelly Chin, et al.
American Heart Journal|June 1, 2002
Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertensionDavid Langleben, Brian W Christman, Robyn J Barst, et al.
American Heart Journal|August 23, 2006
Temporal trends and drug exposures in pulmonary hypertension: an American experienceAlexander M Walker, David Langleben, James J Korelitz, et al.
Pageof 8